CTI BioPharma (CTIC) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
EPS Growth %: +100.0%
Financial Fact:
Selling, general and administrative: 15.22M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +100.0%
Financial Fact:
Selling, general and administrative: 15.22M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q3 EPS of ($0.19), $0.07 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $1 million versus the consensus estimate of $16.3 million.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
- Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
